Alzheimer's, Clinical Trials, FDA Corey Hubbard Alzheimer's, Clinical Trials, FDA Corey Hubbard

Could a Gum Disease Bacterium Hold the Key to Fighting Alzheimer's?

Alzheimer's disease, a devastating condition affecting over six million people in the US alone, stands as a formidable challenge in modern medicine, with no established cure currently available. It gradually erodes memory, thinking skills, and eventually, the ability to carry out the simplest tasks, leaving families grappling with profound loss. For decades, researchers

Read More